Literature DB >> 2883502

First results with ICS 205-930 (5-HT3 receptor antagonist) in prevention of chemotherapy-induced emesis.

U Leibundgut, I Lancranjan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2883502     DOI： 10.1016/s0140-6736(87)92159-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  29 in total

1.  The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties.

Authors:  J R Stott; G R Barnes; R J Wright; C J Ruddock
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

2.  Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors.

Authors:  A Hamik; S J Peroutka
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Topographical distribution of 5-HT3 receptor recognition sites in the ferret brain stem.

Authors:  J M Barnes; N M Barnes; B Costall; I L Naylor; R J Naylor; J A Rudd
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-07       Impact factor: 3.000

Review 4.  5-HT3 receptor antagonists. An overview of their present status and future potential in cancer therapy-induced emesis.

Authors:  M S Aapro
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

5.  The effects of gamma-radiation on intestinal motor activity and faecal pellet expulsion in the guinea pig.

Authors:  A Krantis; K Rana; R K Harding
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

6.  Effects of a 5-hydroxytryptamine3 receptor antagonist (ICS 205-930) on colonic motor activity in healthy men.

Authors:  G Stacher; G Gaupmann; C Schneider; G Stacher-Janotta; G Steiner-Mittelbach; T A Abatzi; H Steinringer
Journal:  Br J Clin Pharmacol       Date:  1989-09       Impact factor: 4.335

Review 7.  Pharmacological Agents Affecting Emesis : A Review (Part II).

Authors:  F Mitchelson
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

Review 8.  Tropisetron. A review of the clinical experience.

Authors:  K M de Bruijn
Journal:  Drugs       Date:  1992       Impact factor: 9.546

9.  Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients.

Authors:  L Dogliotti; R A Antonacci; E Pazè; C Ortega; A Berruti; R Faggiuolo
Journal:  Drugs       Date:  1992       Impact factor: 9.546

10.  Compassionate use of a 5-HT3-receptor antagonist, tropisetron, in patients refractory to standard antiemetic treatment.

Authors:  H Bleiberg; S Van Belle; R Paridaens; G De Wasch; L Y Dirix; M Tjean
Journal:  Drugs       Date:  1992       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.